Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (1): 30-34.doi: 10.3969/j.issn.2095-4344.1522

Previous Articles     Next Articles

Bone morphogenetic protein 2 transfected bone marrow mesenchymal stem cells and fibrin glue to promote tendon-bone healing after anterior cruciate ligament reconstruction

Zhu Lequan, Lu Jianhua, Ran Junling, Yang Weibao, Wang Hui   

  1. Department of Orthopedics, Qianjiang Central Hospital of Chongqing (Qianjiang Hospital of Jishou University), Chongqing 409000, China
  • Revised:2018-09-05 Online:2019-01-08 Published:2018-11-28
  • Contact: Lu Jianhua, Master, Department of Orthopedics, Qianjiang Central Hospital of Chongqing (Qianjiang Hospital of Jishou University), Chongqing 409000, China
  • About author:Zhu Lequan, Master, Department of Orthopedics, Qianjiang Central Hospital of Chongqing (Qianjiang Hospital of Jishou University), Chongqing 409000, China

Abstract:

BACKGROUND: The combination of bone marrow mesenchymal stem cells and fibrin glue can improve the early rupture strength and stiffness of the tendon-bone interface after anterior cruciate ligament reconstruction, and promote the early healing of graft and bone tunnel.
OBJECTIVE: To explore the effect of bone morphogenetic protein 2 transfected bone marrow mesenchymal stem cells combined with fibrin glue on the tendon-bone healing after the reconstruction of the anterior cruciate ligament.
METHODS: Adenovirus vector Ad-GFP-bone morphogenetic protein 2 was transfected into bone marrow mesenchymal stem cells, and the expressions of GFP gene and bone morphogenetic protein 2 were detected after 48 hours. Fifty-four New Zealand white rabbits purchased from the Medical Animal Center of Chongqing were randomly divided into blank group, experimental group and control group, with 18 rats in each group. The anterior cruciate ligament reconstruction model was established in each rat. In the experimental group, after 48 hours of transfection, the transfected bone marrow mesenchymal stem cells were mixed with fibrin glue and injected into the tendon-bone interface. In the control group, non-transfected bone marrow mesenchymal stem cells were mixed with fibrin glue and injected into the tendon-bone interface. In the blank group, no treatment was given. After 4, 8, 12 weeks, the femur-tendon-tibia specimens were taken for histological and biomechanical examinations.
RESULTS AND CONCLUSION: (1) After transfection of 48 hours, the cells expressed green fluorescence under the fluorescence microscope, and the transfection efficiency was (86.1±6.3)%. The expression of cytoplasmic bone morphogenetic protein was positive as shown by SP immunohistochemical test, and the positive band of bone morphogenetic protein 2 was detected by western blot. (2) Findings from the hematoxylin-eosin staining showed best better tendon-bone healing in the experimental and control group than the blank group, and the tendon-bone healing was further better in the experimental group than in the control group. (3) The biomechanical results showed that the maximum load and stiffness were ranked as follows: the experimental group > control group > blank group (P < 0.05). Therefore, bone morphogenetic protein 2-transfected bone marrow mesenchymal stem cells combined with fibrin glue can further enhance the tendon-bone healing after anterior cruciate ligament reconstruction. 

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

Key words: Anterior Cruciate Ligament, Bone Morphogenetic Proteins, Bone Marrow, Mesenchymal Stem Cells, Fibrin Tissue Adhesive, Tissue Engineering

CLC Number: